Skip to main content

Table 2 Baseline characteristics of women according to serum 25(OH)D level

From: Associations of serum 25-hydroxyvitamin D with metabolic syndrome and its components in elderly men and women: the Korean Urban Rural Elderly cohort study

Quartile (n)

(ng/mL)

Quartile 1 (n = 487)

(4.10–11.19)

Quartile 2 (n = 491)

(11.20–15.59)

Quartile 3 (n = 484)

(15.60–21.59)

Quartile 4 (n = 487)

(21.60–54.90)

P value

25(OH)D, ng/mL

8.72 ± 1.67

13.28 ± 1.28

18.31 ± 1.70

28.15 ± 5.56

<  0.001

Age, yr

72.16 ± 4.68

71.07 ± 4.71

71.27 ± 4.35

71.45 ± 4.54*†‡

0.001

BMI, kg/m2

24.69 ± 2.92

25.07 ± 3.31

24.74 ± 3.11

23.58 ± 2.85*†‡

< 0.001

Waist, cm

83.49 ± 8.71

83.63 ± 9.13

83.14 ± 8.52

81.07 ± 8.54*†‡

<  0.001

SBP, mmHg

129.69 ± 15.75

128.51 ± 16.42

125.83 ± 15.46

124.69 ± 15.21*

0.026

DBP, mmHg

74.15 ± 7.96

73.32 ± 8.65

72.55 ± 8.75

72.96 ± 9.28

0.451

Current smoking

7 (1.4)

12 (2.4)

5 (1)

5 (1)

0.216

Current drinking

99 (23.2)

91 (20.6)

145 (28.4)

137 (24)

0.043

Exercise

293 (60.2)

308 (62.7)

294 (60.7)

294 (60.4)

0.855

eGFR

81.04 ± 15.49

82.51 ± 13.94

82.74 ± 13.23

83.68 ± 11.50*

0.024

PTH

46.36 ± 19.35

41.12 ± 14.40

37.70 ± 14.11

36.28 ± 13.80*†

<  0.001

Glucose, mg/dL

96.11 ± 16.34

99.40 ± 20.33

98.17 ± 19.57

95.76 ± 15.56†

0.004

Insulin, IU/L

7.63 ± 4.79

8.09 ± 5.69

7.60 ± 5.07

6.85 ± 7.55†

0.011

HOMA-IR

1.85 ± 1.35

2.07 ± 1.67

1.89 ± 1.47

1.68 ± 2.23†

0.005

Total cholesterol, mg/dL

190.70 ± 38.79

185.70 ± 32.22

187.60 ± 36.56

180.07 ±34.45*‡

<  0.001

Triglyceride, mg/dL

143.47 ± 72.92

127.91 ± 61.37

128.05 ± 57.94

115.83 ± 51.41*†‡

<  0.001

HDL cholesterol, mg/dL

49.85 ± 12.58

51.63 ± 12.61

52.29 ± 12.13

52.30 ± 12.12*

0.005

Number of MetS components

2.65 ± 1.29

2.52 ± 1.30

2.50 ± 1.32

2.26 ± 1.31*†‡

<  0.001

  1. Data were shown as mean ± SD or number (%). 25(OH)D, vitamin D3, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, eGFR estimated glomerular filtration rate, HOMA-IR homeostatic model assessment - insulin resistance, HDL high density lipoprotein, MetS metabolic syndrome. * vs. Q1, † vs. Q2, ‡ vs. Q3